146 related articles for article (PubMed ID: 24806224)
1. Isolation and characterization of mammalian cells expressing the Arf promoter during eye development.
Iqbal NS; Xu L; Devitt CC; Skapek SX
Biotechniques; 2014 May; 56(5):239-49. PubMed ID: 24806224
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous activation of p19Arf in pulmonary artery smooth muscle cells.
Solodushko V; Alvarez DF; Viator R; Messerall T; Fouty B
Am J Physiol Lung Cell Mol Physiol; 2011 Apr; 300(4):L642-7. PubMed ID: 21216978
[TBL] [Abstract][Full Text] [Related]
3. p19(Arf) limits primary vitreous cell proliferation driven by PDGF-B.
Iqbal NS; Devitt CC; Sung CY; Skapek SX
Exp Eye Res; 2016 Apr; 145():224-229. PubMed ID: 26778750
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of persistent hyperplastic primary vitreous in mice lacking the arf tumor suppressor gene.
Martin AC; Thornton JD; Liu J; Wang X; Zuo J; Jablonski MM; Chaum E; Zindy F; Skapek SX
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3387-96. PubMed ID: 15452040
[TBL] [Abstract][Full Text] [Related]
5. Persistent hyperplastic primary vitreous due to somatic mosaic deletion of the arf tumor suppressor.
Thornton JD; Swanson DJ; Mary MN; Pei D; Martin AC; Pounds S; Goldowitz D; Skapek SX
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):491-9. PubMed ID: 17251441
[TBL] [Abstract][Full Text] [Related]
6. p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.
Widau RC; Zheng Y; Sung CY; Zelivianskaia A; Roach LE; Bachmeyer KM; Abramova T; Desgardin A; Rosner A; Cunningham JM; Skapek SX
Mol Cell Biol; 2012 Nov; 32(21):4270-82. PubMed ID: 22907756
[TBL] [Abstract][Full Text] [Related]
7. Testis-specific Arf promoter expression in a transposase-aided BAC transgenic mouse model.
Sung CY; Liu YT; Bennett LB; Devitt CC; Skapek SX
Mol Biol Rep; 2019 Dec; 46(6):6243-6252. PubMed ID: 31583563
[TBL] [Abstract][Full Text] [Related]
8. Transient expression of the Arf tumor suppressor during male germ cell and eye development in Arf-Cre reporter mice.
Gromley A; Churchman ML; Zindy F; Sherr CJ
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6285-90. PubMed ID: 19339492
[TBL] [Abstract][Full Text] [Related]
9. Changes in p19Arf localization accompany apoptotic crisis during pre-B-cell transformation by Abelson murine leukemia virus.
Zimmerman RS; Rosenberg N
J Virol; 2008 Sep; 82(17):8383-91. PubMed ID: 18579612
[TBL] [Abstract][Full Text] [Related]
10. miR-34a is essential for p19(Arf)-driven cell cycle arrest.
Iqbal N; Mei J; Liu J; Skapek SX
Cell Cycle; 2014; 13(5):792-800. PubMed ID: 24401748
[TBL] [Abstract][Full Text] [Related]
11. Differential manifestation of ocular phenotypes in TALEN-mediated p19
Park JS; Kim JI; Lim HJ; Ryu SK; Kwon E; Han KM; Nam KT; Lee HW; Kang BC
Genes Genomics; 2020 Sep; 42(9):1023-1033. PubMed ID: 32712838
[TBL] [Abstract][Full Text] [Related]
12. Tgfbeta signaling directly induces Arf promoter remodeling by a mechanism involving Smads 2/3 and p38 MAPK.
Zheng Y; Zhao YD; Gibbons M; Abramova T; Chu PY; Ash JD; Cunningham JM; Skapek SX
J Biol Chem; 2010 Nov; 285(46):35654-64. PubMed ID: 20826783
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Arf tumor suppressor gene is controlled by Tgfbeta2 during development.
Freeman-Anderson NE; Zheng Y; McCalla-Martin AC; Treanor LM; Zhao YD; Garfin PM; He TC; Mary MN; Thornton JD; Anderson C; Gibbons M; Saab R; Baumer SH; Cunningham JM; Skapek SX
Development; 2009 Jun; 136(12):2081-9. PubMed ID: 19465598
[TBL] [Abstract][Full Text] [Related]
14. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development.
McKeller RN; Fowler JL; Cunningham JJ; Warner N; Smeyne RJ; Zindy F; Skapek SX
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3848-53. PubMed ID: 11891301
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific p19Arf regulation dictates the response to oncogenic K-ras.
Young NP; Jacks T
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10184-9. PubMed ID: 20479239
[TBL] [Abstract][Full Text] [Related]
16. Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of
van Oosterwijk JG; Li C; Yang X; Opferman JT; Sherr CJ
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7420-7425. PubMed ID: 28652370
[TBL] [Abstract][Full Text] [Related]
17. Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin.
Tamase A; Muraguchi T; Naka K; Tanaka S; Kinoshita M; Hoshii T; Ohmura M; Shugo H; Ooshio T; Nakada M; Sawamoto K; Onodera M; Matsumoto K; Oshima M; Asano M; Saya H; Okano H; Suda T; Hamada J; Hirao A
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17163-8. PubMed ID: 19805150
[TBL] [Abstract][Full Text] [Related]
18. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
19. The Arf tumor suppressor regulates platelet-derived growth factor receptor beta signaling: a new view through the eyes of Arf(-/-) mice.
Thornton JD; Silva RL; Martin AC; Skapek SX
Cell Cycle; 2005 Oct; 4(10):1316-9. PubMed ID: 16205116
[TBL] [Abstract][Full Text] [Related]
20. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
